Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06568172
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-22
Brief Title:
Testing the Addition of an Immunotherapy Drug Cemiplimab REGN2810 Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer
Sponsor:
Organization:
None